FDA approves Tecartus, cell-based gene therapy to treat relapsed or refractory MCL in adults
It also received ‘Orphan Drug’ designation, which provides incentives to assist and encourage the development of drugs for rare…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Kite Pharma
Cancer CART therapy: What are the benefits and stakes?
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…